CDH1 and breast cancer: In addition, clinical studies have shown that reduced or impaired E‐cadherin expression in breast cancer is associated with poor prognostic indicators such as larger tumor size, higher histological grade, development of distant metastases, ER‐negative tumors as well as decreased disease‐free and overall survival (Singhai et al., 2011).